Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a cancer vaccine therapy in combination with sargramostim for non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cancer vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED